Skip to main content
. 2014 Jun 9;2014:934732. doi: 10.1155/2014/934732

Figure 3.

Figure 3

Effects of SPRT on the histopathological changes in liver of rats treated with CCl4. (a) Normal controls; (b) disease model group; (c) bifendate + 0.1% of CCl4; (d) SPRT (0.3 g/kg) and 0.1% of CCl4 group; (e) SPRT (0.6 g/kg) and 0.1% of CCl4 group; (f) SPRT (1.2 g/kg) and 0.1% of CCl4 group. HE staining; original magnification ×400.